Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$76,956,955
+$5,091,190 QoQ
Shares Held
1,070,929
+76.2% QoQ
Ownership
0.259%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#67
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. ZTS ranks #3 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,818,037 | $643,491,951 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
546,002 | $295,840,259 | |
| 3 | ZTS |
Zoetis Inc.
This page
|
1,070,929 | $76,956,955 | |
| 4 | VTRS |
Viatris Inc
|
4,694,966 | $74,556,056 | |
| 5 | PRGO |
PERRIGO Co plc
|
3,480,666 | $36,164,117 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
261,250 | $28,983,071 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
6,465,921 | $27,221,524 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,525,686 | $24,456,745 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $76,956,955 | 1,070,929 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $71,865,765 | 607,950 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $100,999,611 | 802,731 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $225,137,753 | 1,538,667 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $190,979,486 | 1,224,620 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $101,487,128 | 616,381 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $47,845,697 | 293,658 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $51,371,652 | 262,932 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $16,899,131 | 97,480 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $14,453,409 | 85,417 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $15,084,593 | 76,428 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $11,539,744 | 66,328 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,499,573 | 43,549 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $30,746,960 | 184,733 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $32,222,388 | 219,873 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $52,100,208 | 351,340 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $83,872,006 | 487,940 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $133,530,960 | 708,049 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $179,514,079 | 735,623 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $136,380,631 | 702,486 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $91,644,951 | 491,763 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $80,429,602 | 510,729 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $87,805,362 | 530,546 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $89,673,039 | 542,257 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $78,293,692 | 571,320 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $95,482,248 | 811,303 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||